MSI-CRC tumours frequently harbour mutations in tumour suppressor genes such as KRAS and pro-oncogenic genes, including BRAF; the V600E mutation in BRAF in particular is characteristic of sporadic MSI-CRC [55]. Here, KRAS is linked to neoplasm.